Sun Pharma Advanced Research Company Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Sun Pharma Advanced Research Company Profile :

Sun Pharma Advanced Research Company Limited is an Indian company engaged in the business of Pharmaceuticals Research & Development.

Company develops anti-cancer formulation, Biodegradable Implants, Dry powder Inhalation, as well as Anti-inflammatory drugs.


Sun Pharma Advanced Research Company ResultsBSE Code : 532872
NSE Symbol : SPARC
ISIN No. : INE232I01014
Industry : Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Sun Pharma Advanced Research Company or you are an stock market analyst then i am sure you might for Quarterly Results of Sun Pharma Advanced Research Company.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Sun Pharma Advanced Research Company. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Sun Pharma Advanced Research Company.

Sun Pharma Advanced Research Company Q1 Results 2016-17 :

Sun Pharma Advanced Research Company will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Sun Pharma Advanced Research Company will announce its Q2 FY 2016-17 Results in the month of October 2016.

Sun Pharma Advanced Research Company will announce its Q3 FY 2016-17 Results in the month of January 2017.

Sun Pharma Advanced Research Company will announce its Q4 FY 2016-17 Results in the month of April 2017.

Sun Pharma Advanced Research Company will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Sun Pharma Advanced Research Company Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 161.28
Other Income  2.94  –
Total Income  164.22  –
Expenditure  -224.47  –
Interest  -2.16  –
Depreciation  -7.58  –
PBT  -69.99  –
Tax  –  –
Net Profit  -69.99  –
Equity  23.67  –
EPS  -2.96  –

Note : If you like this information about Sun Pharma Advanced Research Company Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.